Orthofix Medical Inc. (OFIX)
Orthofix Medical Statistics
Share Statistics
Orthofix Medical has 39.02M shares outstanding. The number of shares has increased by 3.98% in one year.
Shares Outstanding | 39.02M |
Shares Change (YoY) | 3.98% |
Shares Change (QoQ) | 2.12% |
Owned by Institutions (%) | 85.86% |
Shares Floating | 37.33M |
Failed to Deliver (FTD) Shares | 883 |
FTD / Avg. Volume | 0.42% |
Short Selling Information
The latest short interest is 707.85K, so 1.81% of the outstanding shares have been sold short.
Short Interest | 707.85K |
Short % of Shares Out | 1.81% |
Short % of Float | 1.86% |
Short Ratio (days to cover) | 3.17 |
Valuation Ratios
The PE ratio is -5.37 and the forward PE ratio is -19. Orthofix Medical's PEG ratio is 0.27.
PE Ratio | -5.37 |
Forward PE | -19 |
PS Ratio | 0.83 |
Forward PS | 0.5 |
PB Ratio | 1.32 |
P/FCF Ratio | -73.28 |
PEG Ratio | 0.27 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Orthofix Medical.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.36.
Current Ratio | 2.57 |
Quick Ratio | 1.45 |
Debt / Equity | 0.36 |
Debt / EBITDA | -9.85 |
Debt / FCF | -19.77 |
Interest Coverage | -2.86 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $494.73K |
Profits Per Employee | $-76.66K |
Employee Count | 1,616 |
Asset Turnover | 0.89 |
Inventory Turnover | 1.34 |
Taxes
Income Tax | 2.12M |
Effective Tax Rate | -1.71% |
Stock Price Statistics
The stock price has increased by -0.38% in the last 52 weeks. The beta is 1, so Orthofix Medical's price volatility has been higher than the market average.
Beta | 1 |
52-Week Price Change | -0.38% |
50-Day Moving Average | 16.29 |
200-Day Moving Average | 16.82 |
Relative Strength Index (RSI) | 28.76 |
Average Volume (20 Days) | 208.89K |
Income Statement
In the last 12 months, Orthofix Medical had revenue of 799.49M and earned -123.88M in profits. Earnings per share was -3.3.
Revenue | 799.49M |
Gross Profit | 545.88M |
Operating Income | -84.62M |
Net Income | -123.88M |
EBITDA | -18.24M |
EBIT | -94.24M |
Earnings Per Share (EPS) | -3.3 |
Balance Sheet
The company has 83.24M in cash and 179.63M in debt, giving a net cash position of -96.39M.
Cash & Cash Equivalents | 83.24M |
Total Debt | 179.63M |
Net Cash | -96.39M |
Retained Earnings | -276.14M |
Total Assets | 893.29M |
Working Capital | 264.66M |
Cash Flow
In the last 12 months, operating cash flow was 25.79M and capital expenditures -34.88M, giving a free cash flow of -9.09M.
Operating Cash Flow | 25.79M |
Capital Expenditures | -34.88M |
Free Cash Flow | -9.09M |
FCF Per Share | -0.24 |
Margins
Gross margin is 68.28%, with operating and profit margins of -10.58% and -15.49%.
Gross Margin | 68.28% |
Operating Margin | -10.58% |
Pretax Margin | -15.49% |
Profit Margin | -15.49% |
EBITDA Margin | -2.28% |
EBIT Margin | -10.58% |
FCF Margin | -1.14% |
Dividends & Yields
OFIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for OFIX is $24, which is 82.2% higher than the current price. The consensus rating is "Buy".
Price Target | $24 |
Price Target Difference | 82.2% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Scores
Altman Z-Score | 1.25 |
Piotroski F-Score | 5 |